HS

Himanshu Shekhar

Active Director Director DIN 07433985
DIN 07433985 First appointment Feb 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2016
Shareholding value •••• Premium profile

About Himanshu Shekhar

Data last updated:

Himanshu Shekhar is a Director at Esteve Pharma Limited (since 2016). The company operates in Pharma. Esteve Pharma Limited reported revenue of ₹7.63 Cr (FY 2024).

DIN 07433985
Primary Designation Director
Industry Pharma
First Appointment 15 Feb 2016
Oldest Company Age 10 yrs
Largest company Esteve Pharma Limited · ₹7.63 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Esteve Pharma Limited U74900UR2016PLC001918
Director15 Feb 20162016₹7.63 Cr (FY 2024)Active

Board colleagues of Himanshu Shekhar

NameDINCompanyDesignation
Sarwavash Kumar10661403Esteve Pharma LimitedDirector
Shruti Tiwari07439137Esteve Pharma LimitedDirector

Directorship timeline

Open interactive timeline →
Esteve Pharma Limited
Premium access

Shareholding and investment profile for Himanshu Shekhar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Himanshu Shekhar

Himanshu Shekhar currently holds 1 directorship: Esteve Pharma Limited (Director, since 15 Feb 2016, revenue ₹7.63 Cr (FY 2024)).

Himanshu Shekhar was first appointed on 15 Feb 2016 as Director at Esteve Pharma Limited.

The current boards of Himanshu Shekhar's companies include Sarwavash Kumar (Esteve Pharma Limited), Shruti Tiwari (Esteve Pharma Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available